The WHO recommended GLP-1s as a treatment for obesity alongside a healthy diet and regular exercise. Milles Team/Stocksy The World Health Organization (WHO) has recommended the use of GLP-1 ...

The real question is: Why are we even here? Using GLP-1 injections for preventable diet-related diseases in children is a ...

The World Health Organization is officially backing popular weight-loss drugs like Ozempic and Wegovy. The WHO published new guidelines about glucagon-like peptide-1 (GLP-1) medications in the medical ...

Add Yahoo as a preferred source to see more of our stories on Google. In a move that could reshape how doctors approach both weight and heart health, the American College of Cardiology (ACC) released ...

Isabella Cueto covers the leading causes of death and disability: chronic diseases. Her focus includes autoimmune conditions and diseases of the lungs, kidneys, liver (and more). She writes about ...

GLP-1 receptor agonists for obesity are effective over the long term when paired with lifestyle interventions, but global accessibility must be improved, the World Health Organization (WHO) concluded.

A new World Health Organization (WHO) guideline recommending GLP-1s for obesity treatment along with recent efforts to reduce the drugs’ costs are unlikely to change US obesity practice — but actions ...

GLP-1 drugs now have new guidelines The World Health Organization has laid down its first guidelines for GLP-1 drugs like Wegovy and Zepbound.

The World Health Organization (WHO) has recommended the use of GLP-1 medications as part of treatment programs to help people manage obesity. In a new guideline published in JAMA, WHO officials said ...

American Academy of Pediatrics guidelines that set off a new era in obesity treatment — and a national debate about whether children should be prescribed weight loss drugs — may have been shaped by ...